Biliary atresia

Recent progress

Mikelle Bassett, Karen F. Murray

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Extrahepatic biliary atresia (EHBA), an inflammatory sclerosing cholangiopathy, is the leading indication for liver transplantation in children. The cause is still unknown, although possible infectious, genetic, and immunologic etiologies have received much recent focus. These theories are often dependent on each other for secondary or coexisting mechanisms. Concern for EHBA is raised by a cholestatic infant, but the differential diagnosis is large and the path to diagnosis remains varied. Current treatment is surgical with an overall survival rate of approximately 90%. The goals of this article are to review the important clinical aspects of EHBA and to highlight some of the more recent scientific and clinical developments contributing to our understanding of this condition.

Original languageEnglish (US)
Pages (from-to)720-729
Number of pages10
JournalJournal of Clinical Gastroenterology
Volume42
Issue number6
DOIs
StatePublished - Jul 2008
Externally publishedYes

Fingerprint

Biliary Atresia
Liver Transplantation
Differential Diagnosis
Therapeutics

Keywords

  • Biliary atresia
  • Chronic liver disease
  • Liver transplantation
  • Pediatrics
  • Portoenterostomy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Biliary atresia : Recent progress. / Bassett, Mikelle; Murray, Karen F.

In: Journal of Clinical Gastroenterology, Vol. 42, No. 6, 07.2008, p. 720-729.

Research output: Contribution to journalArticle

Bassett, Mikelle ; Murray, Karen F. / Biliary atresia : Recent progress. In: Journal of Clinical Gastroenterology. 2008 ; Vol. 42, No. 6. pp. 720-729.
@article{4f490e24b12c4d55b774e97f1df14ac2,
title = "Biliary atresia: Recent progress",
abstract = "Extrahepatic biliary atresia (EHBA), an inflammatory sclerosing cholangiopathy, is the leading indication for liver transplantation in children. The cause is still unknown, although possible infectious, genetic, and immunologic etiologies have received much recent focus. These theories are often dependent on each other for secondary or coexisting mechanisms. Concern for EHBA is raised by a cholestatic infant, but the differential diagnosis is large and the path to diagnosis remains varied. Current treatment is surgical with an overall survival rate of approximately 90{\%}. The goals of this article are to review the important clinical aspects of EHBA and to highlight some of the more recent scientific and clinical developments contributing to our understanding of this condition.",
keywords = "Biliary atresia, Chronic liver disease, Liver transplantation, Pediatrics, Portoenterostomy",
author = "Mikelle Bassett and Murray, {Karen F.}",
year = "2008",
month = "7",
doi = "10.1097/MCG.0b013e3181646730",
language = "English (US)",
volume = "42",
pages = "720--729",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Biliary atresia

T2 - Recent progress

AU - Bassett, Mikelle

AU - Murray, Karen F.

PY - 2008/7

Y1 - 2008/7

N2 - Extrahepatic biliary atresia (EHBA), an inflammatory sclerosing cholangiopathy, is the leading indication for liver transplantation in children. The cause is still unknown, although possible infectious, genetic, and immunologic etiologies have received much recent focus. These theories are often dependent on each other for secondary or coexisting mechanisms. Concern for EHBA is raised by a cholestatic infant, but the differential diagnosis is large and the path to diagnosis remains varied. Current treatment is surgical with an overall survival rate of approximately 90%. The goals of this article are to review the important clinical aspects of EHBA and to highlight some of the more recent scientific and clinical developments contributing to our understanding of this condition.

AB - Extrahepatic biliary atresia (EHBA), an inflammatory sclerosing cholangiopathy, is the leading indication for liver transplantation in children. The cause is still unknown, although possible infectious, genetic, and immunologic etiologies have received much recent focus. These theories are often dependent on each other for secondary or coexisting mechanisms. Concern for EHBA is raised by a cholestatic infant, but the differential diagnosis is large and the path to diagnosis remains varied. Current treatment is surgical with an overall survival rate of approximately 90%. The goals of this article are to review the important clinical aspects of EHBA and to highlight some of the more recent scientific and clinical developments contributing to our understanding of this condition.

KW - Biliary atresia

KW - Chronic liver disease

KW - Liver transplantation

KW - Pediatrics

KW - Portoenterostomy

UR - http://www.scopus.com/inward/record.url?scp=54749127831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54749127831&partnerID=8YFLogxK

U2 - 10.1097/MCG.0b013e3181646730

DO - 10.1097/MCG.0b013e3181646730

M3 - Article

VL - 42

SP - 720

EP - 729

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 6

ER -